Skip to main
MDAI

MDAI Stock Forecast & Price Target

MDAI Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Spectral AI Inc is positioned for significant growth, with projected revenue expected to increase at a compound annual growth rate (CAGR) of over 69% from FY26 through FY30 following the commercial launch of its DeepView System. The company's revised revenue guidance for FY26 projects research and development revenues of $18.5 million, a substantial increase from previous estimates, signaling enhanced market confidence and operational performance. Additionally, Spectral AI's licensing model is anticipated to generate recurring revenue with high margins, contributing to the stability and predictability of its growth trajectory in the MedTech sector.

Bears say

Spectral AI Inc has lowered its fiscal year 2025 revenue guidance for the BARDA contract to approximately $18.5 million, representing a 37.6% year-over-year decrease from prior expectations of $21.5 million, primarily due to the timing of contract work and impacts from a government shutdown. Furthermore, the company anticipates a decline in revenue for fiscal year 2026 compared to fiscal year 2025, indicating ongoing challenges in clinical and regulatory development timelines that could further negatively affect BARDA-related revenues. Additionally, while general and administrative expenses have decreased by 11.1% year-over-year to $4.0 million, the overall outlook remains pessimistic given the uncertainties surrounding funding and the operational effectiveness of the DeepView System.

MDAI has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Spectral AI Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Spectral AI Inc (MDAI) Forecast

Analysts have given MDAI a Strong Buy based on their latest research and market trends.

According to 1 analysts, MDAI has a Strong Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $3, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $3, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Spectral AI Inc (MDAI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.